Ocumetics Technology Corp.

OTC

CA67577H1047

Office Equipment

Market Closed - Toronto S.E. Other stock markets 01:04:15 14/05/2024 am IST			5-day change	1st Jan Change
0.31 ^CAD	-6.06%		+3.33%	-8.82%

11/04	Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
17/01	Ocumetics Technology Corp. announced that it has received CAD 0.4166 million in funding	CI

Ocumetics Technology Corp. announced that it has received CAD 1 million in funding

August 14, 2023

On August 14, 2023, Ocumetics Technology Corp. closed the transaction. The company issued 1,452,465 units for aggregate gross proceeds of CAD 435,739.60 in its second and final tranche.

The TSX Venture Exchange has accepted for filing documentation with respect to the transaction. The transaction included participation from 22 placees.

Latest news about Ocumetics Technology Corp.

Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	11/04	CI
Ocumetics Technology Corp. announced that it has received CAD 0.4166 million in funding	17/01	CI
Ocumetics Technology Corp. Announces Successful Completion of Animal Study in Preparation for Its First-In-Human Study, Anticipated to Commence in First Quarter of 2024 in the Dominican Republic	07/12	CI
Ocumetics Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Ocumetics Technology Corp. announced that it expects to receive CAD 1 million in funding	15/11	CI
Ocumetics Continues to Meet Significant Development Milestones Lens Design Optimized for Upcoming First in Human Study	18/23/18	CI
Ocumetics Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/23/28	CI
Ocumetics Technology Corp. announced that it has received CAD 1 million in funding	14/23/14	CI
Ocumetics Technology Corp. announced that it expects to receive CAD 1 million in funding	22/23/22	CI
Ocumetics Technology Corp. Announces CEO Changes	12/23/12	CI
Ocumetics Technology Corp. Announces Executive Changes	12/23/12	CI
Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	26/23/26	CI
Ocumetics Technology Corp. Announces Resignation of Dr. Mark Lee as the President to Take Effect from June 30, 2023	25/23/25	CI
Ocumetics Technology Corp. Announces Resignation of Dr. Mark Lee as Chief Executive Officer, Effective from June 30, 2023	25/23/25	CI
Ocumetics Technology Corp. Auditor Raises 'Going Concern' Doubt	25/23/25	CI
Ocumetics Technology Corp. Announces Successful Completion of Animal Studies	13/23/13	CI
Ocumetics Technology Corp. announced that it has received CAD 0.672108 million in funding	01/23/01	CI
Ocumetics Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/22/17	CI
Ocumetics Technology Corp. announced that it expects to receive CAD 2.25 million in funding	19/22/19	CI
Ocumetics Technology Corp.' Lens Technology Delivers 14-Diopters of Accommodation in Bench Studies	30/22/30	CI
Ocumetics Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	20/22/20	CI
Ocumetics Technology Corp. Provides an Update on Preclinical Bench Test Results of its Lens Technologies	24/22/24	CI
Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/22/20	CI
Ocumetics Technology Corp. Provides Update on Preclinical Studies	19/22/19	CI

Chart Ocumetics Technology Corp.

Duration

Period

More charts

Company Profile

Ocumetics Technology Corp. is a Canada-based research and product development company. The Company specializes in adaptive lens designs. The Company is focused on developing intraocular lens for people over 45 years of age. It is in the preclinical study stage of a technology for the ophthalmic industry. The Bionic Lens, which is an expandable intraocular lens that fits within the natural lens compartment of the eye to eliminate the need for corrective lenses. It is designed to allow the eyeâs natural muscle activity to shift focus from distance to nearby. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lensâs suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipientâs eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.

Sector

Office Equipment

Calendar

15/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Scientific & Precision Equipment

	1st Jan change	Capi.
OCUMETICS TECHNOLOGY CORP.	-8.82%	2.71Cr
SHIMADZU CORPORATION	+12.40%	846.6Cr
TECAN GROUP AG	-3.67%	465.95Cr
OLINK HOLDING AB	-6.52%	292.33Cr
JEOL LTD.	+5.75%	217.94Cr
NINGBO YONGXIN OPTICS CO.,LTD	-26.91%	111.61Cr
ECKERT & ZIEGLER SE	+1.55%	91Cr
PARK SYSTEMS CORP.	-6.74%	82Cr
FOCUSED PHOTONICS (HANGZHOU), INC.	-23.28%	75Cr
PHENIX OPTICAL COMPANY LIMITED	-24.57%	67Cr

Scientific & Precision Equipment